Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07342426

High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis

Comparison of the Effects of High and Low Dose High-intensity Laser Therapy in Patients With Lateral Epicondylitis

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

High-intensity laser therapy has gained increasing attention in recent years as a therapeutic modality. It is a non-invasive treatment that can reduce pain, increase local blood circulation, and promote tissue repair. The higher energy output of high-intensity laser therapy also have deeper tissue penetration. Several studies have investigated the effects of high-intensity laser therapy on lateral epicondylitis, and the existing literature indicates that, compared with other treatment modalities, high-intensity laser therapy is more effective in improving pain and quality of life in patients with lateral epicondylitis. However, the dosage, duration, and treatment frequency applied in previous studies vary considerably. The therapeutic effects of high-intensity laser therapy may therefore be influenced by treatment dosage. Consequently, the purpose of this study is to compare the effects of two different dosages of high-intensity laser therapy on patients with lateral epicondylitis.

Conditions

Interventions

TypeNameDescription
DEVICEHigh intensity laser therapyUsing high-intensity laser therapy applying on the affected area.
DEVICEInfarred ray therapy systemUsing infarred ray therapy applying on affected area for 15 minutes.
DEVICETranscutaneous electrical nerve stimulatorUsing transcutaneous electrical nerve stimulator on the affected area fior 15 minutes.

Timeline

Start date
2026-01-12
Primary completion
2026-02-06
Completion
2026-12-06
First posted
2026-01-15
Last updated
2026-01-21

Locations

1 site across 1 country: Taiwan

Regulatory

Source: ClinicalTrials.gov record NCT07342426. Inclusion in this directory is not an endorsement.